Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes

This publication has 13 references indexed in Scilit:

• The value of varicella vaccination in healthy children: cost–benefit analysis of the situation in France
  Vaccine, 1999
• Study Designs for Evaluating Different Efficacy and Effectiveness Aspects of Vaccines
  American Journal of Epidemiology, 1997
• Over five-year follow-up of Oka/Merck varicella vaccine recipients in 465 infants and adolescents
  The Pediatric Infectious Disease Journal, 1995
• Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine
  The Journal of Pediatrics, 1995
• Imperfect vaccines and herd immunity to HIV
  Proceedings Of The Royal Society B-Biological Sciences, 1993
• Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies
  Vaccine, 1991
• Live Oka/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment
  1985
• Live Attenuated Varicella Virus Vaccine
  New England Journal of Medicine, 1984
• Varicella Vaccine Trials in Healthy Children
  American Journal of Diseases of Children, 1984
• Live attenuated varicella vaccine: Immunization of healthy children with the OKA strain
  The Journal of Pediatrics, 1982